Ciclopirox Olamine
- Generic Name
- Ciclopirox Olamine
Overview
No overview information available.
Background
No background information available.
Indication
外用于治疗由皮肤癣菌如红色毛癣菌、须癣毛癣菌。絮状表皮癣菌和犬小孢子菌等所致的浅表皮肤真菌感染，如手癣、足癣（尤其是角化增厚型）、体癣、股癣；亦可用于头癣；也适用于治疗甲真菌病。外用于由念珠菌如白色念珠菌等所致的皮肤念珠菌感染和念珠菌性外阴阴道炎。外用于由马拉色菌属所致的花斑癣。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Ciclopirox Olamine
Manufacturer:Bryant Ranch Prepack
Route:TOPICAL
Strength:7.7 mg in 1 g
Approved: 2023/07/17
NDC:63629-8626
Ciclopirox Olamine
Manufacturer:Padagis Israel Pharmaceuticals Ltd
Route:TOPICAL
Strength:7.7 mg in 1 g
Approved: 2017/01/03
NDC:45802-138
Ciclopirox
Manufacturer:E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Route:TOPICAL
Strength:7.7 mg in 1 mL
Approved: 2014/08/15
NDC:0168-0314
Ciclopirox Olamine
Manufacturer:Physicians Total Care, Inc.
Route:TOPICAL
Strength:7.7 mg in 1 g
Approved: 2013/02/19
NDC:54868-5270
Ciclopirox Olamine
Manufacturer:Bryant Ranch Prepack
Route:TOPICAL
Strength:7.7 mg in 100 mL
Approved: 2023/07/17
NDC:63629-8627
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath